Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN111285760B details a novel Suzuki coupling route for Bempedoic acid, eliminating column chromatography to ensure high purity and scalable API intermediate manufacturing.
Patent CN1829722A details a regioselective boronate route for CCI-779, eliminating chromatography for cost-effective API intermediate manufacturing.
Novel synthesis of monoamine inhibitor intermediate via selenylation. High purity, scalable route for pharmaceutical supply chains.
Novel hydrogenation-cyclization route offers high yield and mild conditions for scalable production of protected diazaspiro compounds.
Patent CN1189458C details a chiral pool synthesis of key Substance P antagonists. Discover cost-effective manufacturing and supply chain advantages.
Patent CN1266145C reveals a novel ester-mediated synthesis of Δ9-THC, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing without heavy metal residues.
Patent CN107880063B details high-yield dauricine synthesis. This method offers significant supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing globally.
Advanced preparation method for olmesartan medoxomil intermediates using novel tetrazole protection. Reduces impurities and simplifies purification for API manufacturing.
Novel asymmetric 3,5-diarylmethylene-4-piperidones with anti-tumor activity. Efficient Claisen-Schmidt synthesis route ensures scalable production for pharma partners.
Novel isopropanol-water solvent system enhances yield and purity for DPP-IV inhibitors. Reduces reaction time and simplifies purification for reliable pharmaceutical intermediate supply.
Patent CN107245064B details a safer synthesis route for Sofosbuvir intermediates offering high yield and supply chain stability for pharmaceutical manufacturing.
Patent CN106748853B reveals high-yield asymmetric synthesis for Clopidogrel intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN120795005A enables high-purity chiral alkyl boron synthesis using cobalt catalysts. Delivers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112679407B details a cost-effective 4-step route for chiral prolines. Ideal for diabetes and epilepsy drug synthesis with high scalability.
Patent CN115109118A introduces a solid-phase synthesis method for DS-8201 intermediates, offering superior purity and cost reduction for ADC manufacturing.
Patent CN116987748A reveals one-step enzymatic route for pseudouridylic acid. Offers high yield and cost reduction for pharmaceutical intermediates manufacturing supply chains.
Patent CN107935950B reveals a scalable synthesis for broad-spectrum antibacterial triazole derivatives, offering cost-effective solutions for API manufacturing.
Novel catalytic route for Ramelteon intermediate reduces by-products and enhances supply chain stability for pharmaceutical manufacturing partners globally.
Novel synthetic route for Favipiravir intermediate ensuring high yield and scalable production for global pharmaceutical supply chains and significant cost reduction.
Novel patent CN107628999A enables high yield Aripiprazole dodecylate synthesis without column chromatography ensuring supply chain stability and cost efficiency for global buyers.